Clinical Trial Update: Sublingual Apomorphine in Refractory Restless Legs Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating sublingual apomorphine for refractory Restless Legs Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Apomorphine (sublingual formulation) (apomorphine)

Snippet

Sponsor: William Ondo, MD | Conditions: Restless Legs Syndrome | Phase 4 | Status: UNKNOWN